Analysts Set The Clorox Company (NYSE:CLX) PT at $155.00

The Clorox Company (NYSE:CLXGet Free Report) has been given an average rating of “Reduce” by the fifteen analysts that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $155.00.

Several equities research analysts recently weighed in on CLX shares. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Barclays lifted their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. Citigroup upped their price objective on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. DA Davidson lifted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st.

Read Our Latest Analysis on Clorox

Institutional Investors Weigh In On Clorox

Large investors have recently added to or reduced their stakes in the business. Prospera Private Wealth LLC bought a new position in shares of Clorox during the 3rd quarter worth about $27,000. Innealta Capital LLC acquired a new position in Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC boosted its holdings in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares in the last quarter. Continuum Advisory LLC grew its stake in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the period. Finally, Family Firm Inc. bought a new stake in shares of Clorox during the second quarter valued at approximately $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 0.2 %

CLX stock opened at $167.73 on Friday. The firm has a 50-day moving average price of $163.59 and a 200-day moving average price of $150.86. Clorox has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a market capitalization of $20.76 billion, a P/E ratio of 58.42, a price-to-earnings-growth ratio of 3.08 and a beta of 0.42.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue was up 27.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 EPS. As a group, equities research analysts anticipate that Clorox will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is 170.04%.

Clorox Company Profile

(Get Free Report

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.